| mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
6e-05 |
| mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0002 |
| mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
| mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
| mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
0.39 |
0.003 |